Atazanavir, 98%, an highly potent HIV-1 protease inhibitor

Name: Atazanavir, 98%, an highly potent HIV-1 protease inhibitor | 198904-31-3
Brand: J&K Chemical
SKU: JK622208_5_MG
Price: 38.0 USD
Availability: OutOfStock

Cat. No JK622208_5_MG

Vendor: J&K Chemical

Product Information

Product Name

Atazanavir, 98%, an highly potent HIV-1 protease inhibitor

Brand Name

J&K

Product Number

622208

CAS

198904-31-3

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

148192

IUPAC Name

methyl N-(2S)-1-2-(2S,3S)-2-hydroxy-3-(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoylamino-4-phenylbutyl-2-(4-pyridin-2-ylphenyl)methylhydrazinyl-3,3-dimethyl-1-oxobutan-2-ylcarbamate

InChI Key

AXRYRYVKAWYZBR-GASGPIRDSA-N

SMILES

CC(C)(C)C@@H(C(=O)NC@@H(CC1=CC=CC=C1)C@H(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C@H(C(C)(C)C)NC(=O)OC)O)NC(=O)OC

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

S113 | SWISSPHARMA24 | 2024 Swiss Pharmaceutical List with Metabolites

Publication Date: 2026

DOI: 10.5281/zenodo.10501043

How Wastewater Reflects Human Metabolism─Suspect Screening of Pharmaceutical Metabolites in Wastewater Influent

Publication Name: Environmental Science & Technology

Publication Date: 2024-05-24

DOI: 10.1021/acs.est.4c00968

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2023-11-15

DOI: 10.1016/j.ejmech.2023.115772

TTD: Therapeutic Target Database describing target druggability information

Publication Name: Nucleic Acids Research

Publication Date: 2023-09-15

DOI: 10.1093/nar/gkad751

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

Publication Name: Cancer Letters

Publication Date: 2023-08-01

DOI: 10.1016/j.canlet.2023.216284

Atazanavir, 98%, an highly potent HIV-1 protease inhibitor

Product Information

General Information

Safety Information

References Data Source From Pubchem

S113 | SWISSPHARMA24 | 2024 Swiss Pharmaceutical List with Metabolites

How Wastewater Reflects Human Metabolism─Suspect Screening of Pharmaceutical Metabolites in Wastewater Influent

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review

TTD: Therapeutic Target Database describing target druggability information

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma